01830.HK
Perfect Medical Health Management Limited
HKSE · Consumer Cyclical · Personal Products & Services · HK
HKD 1.31
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.1B | 962.3M | 1.1B | 1.4B | 1.4B |
| Cost of Revenue | 937.8M | 507.9M | 408.6M | 482.0M | 726.7M |
| Gross Profit | 1.2B | 454.5M | 719.2M | 911.4M | 662.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 408.9M | 238.2M | 155.4M | 182.7M | 178.2M |
| General & Admin Expense | 27.2M | — | 15.1M | 23.1M | 27.4M |
| Selling & Marketing Expense | 194.9M | — | 140.3M | 159.6M | 150.8M |
| Other Expenses | 275.9M | — | 312.2M | 346.3M | (482.0K) |
| Total Operating Expenses | 684.8M | 238.2M | 467.6M | 529.0M | 293.8M |
| Cost and Expenses | 1.6B | 746.1M | 876.2M | 1.0B | 1.0B |
| Operating Income (EBIT) | 467.6M | 216.3M | 251.6M | 382.4M | 368.8M |
| Non-Operating | |||||
| Interest Income | 17.0M | 6.1M | 12.0M | 12.6M | 7.9M |
| Interest Expense | 19.0M | 7.9M | 11.1M | 11.2M | 12.5M |
| Net Interest Income | (2.1M) | (1.8M) | 913.0K | 1.3M | (4.6M) |
| Other Non-Op Income/Expense | (3.9M) | (5.1M) | 913.0K | 1.3M | 22.6M |
| Non-Operating Income (excl Interest) | (1.7M) | — | (12.0M) | (12.6M) | (9.4M) |
| EBT (Pre-Tax Income) | 463.7M | 211.2M | 252.5M | 383.7M | 391.5M |
| Income Tax Expense | 79.0M | 32.8M | 46.2M | 73.3M | 75.8M |
| Bottom Line | |||||
| Net Income | 385.6M | 178.7M | 206.9M | 315.8M | 315.6M |
| Earnings from Cont. Ops | 384.7M | 178.3M | 206.4M | 310.4M | 315.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 385.6M | 178.7M | 206.9M | 315.8M | 315.6M |
| Per Share | |||||
| Basic EPS | HK$0.30 | HK$0.14 | HK$0.16 | HK$0.25 | HK$0.25 |
| Diluted EPS | HK$0.30 | HK$0.14 | HK$0.16 | HK$0.25 | HK$0.25 |
| Revenue Per Share | HK$1.66 | HK$0.77 | HK$0.90 | HK$1.11 | HK$1.11 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.2B |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.2B |
| Profitability Metrics | |||||
| EBITDA | 692.4M | 369.5M | 442.0M | 596.9M | 592.4M |
| D&A | 223.1M | 153.2M | 178.3M | 202.0M | 223.6M |
| EBIT | 469.4M | 216.3M | 263.6M | 394.9M | 368.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026